Clinical Trials Directory

Trials / Completed

CompletedNCT06655935

Novel Modified Technique for Transcatheter Closure of Secundum Atrial Septal Defect: A Single Center Experience

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Egyptian Biomedical Research Network · Network
Sex
All
Age
3 Years
Healthy volunteers
Not accepted

Summary

Transcatheter closure of secundum atrial septal defects is widely approved worldwide, yet it still has multiple risks like perforation and radiation exposure. In this study, we proposed a modified rapid method for closure of secundum atrial septal defects, to avoid material manipulation inside your heart and decrease complication rate.

Detailed description

Delivery sheath can be advanced over multipurpose catheter instead of stiff wire

Conditions

Interventions

TypeNameDescription
PROCEDUREOrdinary Transcatheter ASD closuredeploying the Amplatzer delivery system of the Amplatzer™ Septal Occluders ASO inside the left atrial cavity over stiff wire into the pulmonary veins
PROCEDUREmodified transcatheter ASD closuredeploying the Amplatzer delivery system of the Amplatzer™ Septal Occluders ASO over the multipurpose catheter inside the left atrial cavity which might help in the shortage of the duration \& the cost of the procedure with less complication rate

Timeline

Start date
2022-06-01
Primary completion
2023-06-01
Completion
2023-06-30
First posted
2024-10-24
Last updated
2024-10-29

Locations

1 site across 1 country: Egypt

Regulatory

Source: ClinicalTrials.gov record NCT06655935. Inclusion in this directory is not an endorsement.